Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Colon polyp Follow-Up: 6 months vs 12 months – which is better?

NCT ID NCT07198945

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a 6-month or 12-month follow-up colonoscopy is better for people who had a large colon polyp (20-50 mm) removed that was not cancerous. About 546 adults will be assigned to one of the two follow-up schedules. The goal is to see which timing finds any returning polyp tissue more effectively and how easy it is to treat.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 546 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Feb 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patient Criteria 1. ≥ 18 years of age 2. Ability to provide informed consent 3. Willing and able to complete one electronic survey 4. Presenting for colonoscopy for any indication 5. Ability to understand the requirements of the study and agree to abide by the study restrictions and to return for the required assessments. Polyp Criteria 6. Size 20-50 mm as documented with photo containing open snare of known size as comparison. 7. Histology without high grade dysplasia: 1. Conventional Adenoma: adenoma with or without villous components 2. Serrated: hyperplastic or sessile serrated lesion Exclusion Criteria: Patient Criteria 1. Patients with confirmed diagnosis of inflammatory bowel disease, including Ulcerative Colitis and Crohn's Disease. 2. Patients with a known or suspected diagnosis of any of the following polyposis or non-polyposis syndromes with known genetic mutations: * Familial Adenomatous Polyposis Syndrome * MUTYH associated Polyposis Syndrome * Juvenile Polyposis Syndrome * Cowden's Syndrome * Peutz-Jeghers Syndrome * Hereditary Non-Polyposis Colorectal Cancer Syndrome (HNPCC) or Lynch Syndrome 3. Patients who have high grade dysplasia found in any polyp ≥ 20 mm removed at the index colonoscopy 4. Patients who have any colorectal cancer by histologic diagnosis at index procedure 5. Patients needing a colonoscopy 6 months or sooner for any indication following the index procedure including burden of synchronous disease, inadequate prep to assess for synchronous disease, inadequate prep that precludes resection of index large polyp, or other reason limiting ability to complete full examination of colon at time of resection. 6. ASA ≥ 4 or documented coagulopathy or severe thrombocytopenia (INR ≥ 2 or platelets ≤ 20). 7. Patients who have more than three ≥ 20mm polyps removed during the index colonoscopy 8. Patients with significant acute or chronic medical, neurologic, or illness that, in the judgment of the Principal Investigator, could compromise subject safety, limit the ability to complete the study, and/or compromise the objectives of the study. Polyp Criteria 9. Polyp located at appendiceal orifice, ileocecal valve, or intradiverticulum 10. Pedunculated or semi-pedunculated polyps (as defined by Paris Classification type Ip or Isp) 11. A polyp that is classified as a traditional serrated adenoma. 12. Polyps with features of invasive cancer 13. Polyps that are not able to be removed with standard endoscopic techniques for any reason 14. Polyps that are incompletely resected endoscopically at index procedure 15. Polyps removed by endoscopic submucosal dissection (ESD) or by full thickness resection device (FTRD)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adenoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    10 sites in 3 countries. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, 02215, United States

  • Henry Ford Hospital

    Detroit, Michigan, 48208, United States

  • Indiana University

    Indianapolis, Indiana, 46202, United States

  • Rush University

    Chicago, Illinois, 60612, United States

  • The University of Kansas Medical Center

    Kansas City, Kansas, 66221, United States

  • University Medical Centre Ljubljana

    Ljubljana, 1000, Slovenia

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35244, United States

  • University of British Columbia

    Vancouver, British Columbia, V5Z 1M9, Canada

  • University of Colorado

    Aurora, Colorado, 80045, United States

  • White River Junction VA Medical Center

    White River Junction, Vermont, 05009, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.